Valeritas announced the launch of V-Go, a basal-bolus insulin delivery device to help control blood glucose in adults with type 2 diabetes.

V-Go comes with a preset basal rate and on-demand bolus dosing that mimics physiologic insulin delivery. It requires only one insulin type with no need for additional insulin shots. A U-100 fast-acting insulin should be used with the V-Go. Humalog (insulin lispro injection [rDNA origin]; Lilly) and NovoLog (insulin aspart injection [rDNA origin]; Novo Nordisk) have been tested and found to be safe for use. V-Go is fully disposable—patients remove and discard the V-Go and apply a new filled V-Go every 24 hours

V-Go is available in three preset basal delivery rates of 0.83U/hr, 1.25U/hr, and 1.67U/hr, with a bolus delivery rate up to 36 units in 2-unit increments. Each kit contains 30 single-use V-Go devices and one EZ Fill filling accessory.

For more information call (866) 881-1209 or visit